(Q48258866)

English

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

0 references

bipolar I disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Terence A Ketter

2

object named as

Terence A Ketter

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

Raymond Sanchez

6

object named as

Raymond Sanchez

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

author name string

Berit X Carlson

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Wei Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Karen Timko

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Robert D McQuade

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Estelle Vester-Blokland

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Ronald Marcus

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Bipolar Disorders

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

14

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

41-53

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Effectiveness of lamotrigine in bipolar disorder in a clinical setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Number needed to treat (NNT): estimation of a measure of clinical benefit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00974.X

21 January 2018

Identifiers

10.1111/J.1399-5618.2011.00974.X

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/22329471

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48258866&oldid=1734797960"